206 related articles for article (PubMed ID: 28726172)
1. Combined treatment for non-small cell lung cancer and breast cancer patients with brain metastases with whole brain radiotherapy and temozolomide: a systematic review and meta-analysis.
Tian J; Luo Y; Xiang J; Tang J
J Neurooncol; 2017 Nov; 135(2):217-227. PubMed ID: 28726172
[TBL] [Abstract][Full Text] [Related]
2. Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer.
Cao KI; Lebas N; Gerber S; Levy C; Le Scodan R; Bourgier C; Pierga JY; Gobillion A; Savignoni A; Kirova YM
Ann Oncol; 2015 Jan; 26(1):89-94. PubMed ID: 25355723
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of whole-brain radiotherapy plus temozolomide compared with whole-brain radiotherapy for the treatment of brain metastases from non-small-cell lung cancer.
Xin Y; Guo W; Yang CS; Huang Q; Zhang P; Zhang LZ; Jiang G
Cancer Med; 2018 Apr; 7(4):981-990. PubMed ID: 29516684
[TBL] [Abstract][Full Text] [Related]
4. Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study.
Siena S; Crinò L; Danova M; Del Prete S; Cascinu S; Salvagni S; Schiavetto I; Vitali M; Bajetta E
Ann Oncol; 2010 Mar; 21(3):655-661. PubMed ID: 19767314
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial.
Mulvenna P; Nankivell M; Barton R; Faivre-Finn C; Wilson P; McColl E; Moore B; Brisbane I; Ardron D; Holt T; Morgan S; Lee C; Waite K; Bayman N; Pugh C; Sydes B; Stephens R; Parmar MK; Langley RE
Lancet; 2016 Oct; 388(10055):2004-2014. PubMed ID: 27604504
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of EGFR-TKI combined with WBRT vs. WBRT alone in the treatment of brain metastases from NSCLC: a systematic review and meta-analysis.
Li S; Xu S; Li L; Xue Z; He L
Front Neurol; 2024; 15():1362061. PubMed ID: 38737351
[TBL] [Abstract][Full Text] [Related]
7. Brain metastases from melanoma: is there a role for concurrent temozolomide in addition to whole brain radiation therapy?
Schild SE; Behl D; Markovic SN; Brown PD; Sande JR; Deming RL; Rowland KM; Bearden JD
Am J Clin Oncol; 2010 Dec; 33(6):633-6. PubMed ID: 20042969
[TBL] [Abstract][Full Text] [Related]
8. Evidence of elemene injection combined radiotherapy in lung cancer treatment among patients with brain metastases: A systematic review and meta-analysis.
Jiang X; Hidru TH; Zhang Z; Bai Y; Kong L; Li X
Medicine (Baltimore); 2017 May; 96(21):e6963. PubMed ID: 28538391
[TBL] [Abstract][Full Text] [Related]
9. [Progress of treatments in non-small cell lung cancer with brain metastases].
Ma C; Jiang R
Zhongguo Fei Ai Za Zhi; 2012 May; 15(5):309-13. PubMed ID: 22613339
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of concurrent immune checkpoint inhibitors combined with radiotherapy or chemoradiotherapy for advanced non-small cell lung cancer: A systematic review and single-arm meta-analysis.
Cui R; Li Y; Yu X; Wei C; Jiang O
PLoS One; 2024; 19(6):e0304941. PubMed ID: 38865375
[TBL] [Abstract][Full Text] [Related]
11. Concurrent Apatinib and Brain Radiotherapy in Patients With Brain Metastases From Driver Mutation-negative Non-small-cell Lung Cancer: Study Protocol for an Open-label Randomized Controlled Trial.
Ma J; Pi G; Bi J; Li Y; He H; Li Y; Hu D; Verma V; Han G
Clin Lung Cancer; 2021 Mar; 22(2):e211-e214. PubMed ID: 33187916
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety analysis of stereotactic body radiotherapy for brain multi-metastases in non-small cell lung cancer patients.
Zhao J; Liu H; Qi T; Zhao H; Ye T; Ning P
Technol Health Care; 2024; 32(1):293-301. PubMed ID: 37393454
[TBL] [Abstract][Full Text] [Related]
13. A meta-analysis for the efficacy and safety of icotinib combined with radiotherapy in treating brain metastases of non-small cell lung cancer.
Zhang B
Medicine (Baltimore); 2023 Sep; 102(36):e34572. PubMed ID: 37682155
[TBL] [Abstract][Full Text] [Related]
14. Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma.
Chamberlain MC; Baik CS; Gadi VK; Bhatia S; Chow LQ
Neuro Oncol; 2017 Jan; 19(1):i1-i24. PubMed ID: 28031389
[TBL] [Abstract][Full Text] [Related]
15. Impact of Locoregional Therapies for Brain Lesions on Survival in Patients With Non-small Cell Lung Cancer With Multiple Extrathoracic Metastases.
Sakai K; Kuramoto J; Takahashi T; Kawano Y; Nishimura H; Kuwabara Y; Kojima A; Sasaki-Toda M; Ogawa-Kobayashi Y; Kikuchi S; Hirata Y; Mikami-Saito Y; Mikami S; Kyoyama H; Moriyama G; Koyama N; Uematsu K
Anticancer Res; 2023 Nov; 43(11):5107-5114. PubMed ID: 37909984
[TBL] [Abstract][Full Text] [Related]
16. Temozolomide in secondary prevention of HER2-positive breast cancer brain metastases.
Zimmer AS; Steinberg SM; Smart DD; Gilbert MR; Armstrong TS; Burton E; Houston N; Biassou N; Gril B; Brastianos PK; Carter S; Lyden D; Lipkowitz S; Steeg PS
Future Oncol; 2020 May; 16(14):899-909. PubMed ID: 32270710
[TBL] [Abstract][Full Text] [Related]
17. Anlotinib combined with whole-brain radiotherapy in non-small cell lung cancer with multiple brain metastases that progressed or developed after at least one lines of prior treatment.
Kong C; Yu S; Qian P; Song X; Wen J; Jiang M; Zhu J; Xu J; Zhao L; Guo Z; Wu J; He X; Zhu X
Front Oncol; 2023; 13():1169333. PubMed ID: 37771446
[TBL] [Abstract][Full Text] [Related]
18. Integration of chemotherapy into current treatment strategies for brain metastases from solid tumors.
Nieder C; Grosu AL; Astner S; Thamm R; Molls M
Radiat Oncol; 2006 Jun; 1():19. PubMed ID: 16800900
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety evaluation of combined therapies incorporating whole-brain radiotherapy in patients with brain metastases: a systematic review and meta-analysis.
Yan Q; Li R; Yang J; Bai X; Guo X; Yang X; Song J
Clin Transl Oncol; 2024 May; ():. PubMed ID: 38789890
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of rare earth carbonate with chemoradiotherapy in late-stage non-small cell lung cancer: a cohort prospective study.
Cao Q; Ye X; Wu X; Zhang Q; Gong J; Chen Y; You Y; Shen J; Qiang Y; Cao G
Front Endocrinol (Lausanne); 2023; 14():1301032. PubMed ID: 38192415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
